GLYC
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$10.13M
-0.3
GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The firm was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The firm was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
Recently from Cashu
GlycoMimetics Stock Update: Key Developments and Market Insights
Please provide the text you'd like me to summarize, and I'll be happy to help.
GlycoMimetics Stock Update: Key Developments and Financial Insights
Please provide the content you'd like me to summarize, and I'll be happy to assist you!
Please provide the content you would like me to summarize.
Please provide the text you would like me to summarize.
GlycoMimetics Stock Update: Key Developments and Insights
Please provide the text you would like me to summarize, and I will be happy to assist you.